James Michael Isaacs

James Isaacs practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

James Isaacs' NPI, 1629423934, was assigned on April 25, 2016. James Isaacs holds Ohio license 35.144466.

James Isaacs' primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

James Isaacs' primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. James Isaacs is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links James Isaacs to 3 more hospitals, 2 clinical labs and 1 group practice or clinic, each named with a free account. James Isaacs' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where James Isaacs practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is James Isaacs' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. James Isaacs is licensed in Ohio.

CMS data shows 448 Medicare services from James Isaacs across 7 procedure codes in 2024, for 167 Medicare patients. Medicare paid $40,970 for them.

CMS counts 167 Medicare patients who saw James Isaacs in 2024. The largest group is 65 to 74, with 86 patients. 74% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts James Isaacs' median patient age at 66, with 41% women.

In 2024, James Isaacs wrote 235 Medicare Part D claims for 52 patients. 77% of them were for generic drugs. CMS names the drug for 118 of them, across 8 drugs with 11 or more claims each, at $6,514 in total drug cost. In 2023, CMS named 83 claims across 3 drugs.

James Isaacs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists James Isaacs as offering telehealth.

Dmand AI links 12 papers to James Isaacs, published from 2020 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Immunotherapy, Carcinoma, Non-Small-Cell Lung and Immune Checkpoint Inhibitors. James Isaacs' most frequent co-authors are Scott Joseph Antonia, MD, Pauline Funchain, MD and Lucy Boyce Kennedy, MD.

CMS Open Payments shows 14 general payments to James Isaacs from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $660.